Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

The role of speed in ADHD-related working memory deficits: A time-based resource-sharing and diffusion model account.

Weigard A, Huang-Pollock C.

Clin Psychol Sci. 2017 Mar;5(2):195-211. doi: 10.1177/2167702616668320. Epub 2016 Dec 21.

PMID:
28533945
2.
3.

Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors.

Ledonne A, Mercuri NB.

Front Cell Neurosci. 2017 Feb 8;11:27. doi: 10.3389/fncel.2017.00027. eCollection 2017. Review.

4.

Optogenetic Stimulation of Frontal D1 Neurons Compensates for Impaired Temporal Control of Action in Dopamine-Depleted Mice.

Kim YC, Han SW, Alberico SL, Ruggiero RN, De Corte B, Chen KH, Narayanan NS.

Curr Biol. 2017 Jan 9;27(1):39-47. doi: 10.1016/j.cub.2016.11.029. Epub 2016 Dec 15.

PMID:
27989675
5.

N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology.

Pusceddu MM, Kelly P, Stanton C, Cryan JF, Dinan TG.

Int J Neuropsychopharmacol. 2016 Dec 30;19(12). pii: pyw078. doi: 10.1093/ijnp/pyw078. Print 2016 Dec. Review.

6.

Counteractive effects of antenatal glucocorticoid treatment on D1 receptor modulation of spatial working memory.

Virdee K, Kentrop J, Jupp B, Venus B, Hensman D, McArthur S, Wilkinson J, Robbins TW, Gillies G, Dalley JW.

Psychopharmacology (Berl). 2016 Oct;233(21-22):3751-3761. Epub 2016 Aug 23.

7.

New drug developments in psychosis: Challenges, opportunities and strategies.

Keshavan MS, Lawler AN, Nasrallah HA, Tandon R.

Prog Neurobiol. 2017 May;152:3-20. doi: 10.1016/j.pneurobio.2016.07.004. Epub 2016 Aug 9. Review.

PMID:
27519538
8.

Dopamine D1 signaling organizes network dynamics underlying working memory.

Roffman JL, Tanner AS, Eryilmaz H, Rodriguez-Thompson A, Silverstein NJ, Ho NF, Nitenson AZ, Chonde DB, Greve DN, Abi-Dargham A, Buckner RL, Manoach DS, Rosen BR, Hooker JM, Catana C.

Sci Adv. 2016 Jun 3;2(6):e1501672. doi: 10.1126/sciadv.1501672. eCollection 2016 Jun.

9.

The relationship between dopamine receptor D1 and cognitive performance.

Tsang J, Fullard JF, Giakoumaki SG, Katsel P, Katsel P, Karagiorga VE, Greenwood TA, Braff DL, Siever LJ, Bitsios P, Haroutunian V, Roussos P.

NPJ Schizophr. 2015 Mar 4;1:14002. doi: 10.1038/npjschz.2014.2. eCollection 2015. Erratum in: NPJ Schizophr. 2015;1:15018.

10.

COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review.

Schacht JP.

Pharmacogenomics J. 2016 Oct;16(5):430-8. doi: 10.1038/tpj.2016.43. Epub 2016 May 31. Review.

11.

Pathway-Specific Dopamine Abnormalities in Schizophrenia.

Weinstein JJ, Chohan MO, Slifstein M, Kegeles LS, Moore H, Abi-Dargham A.

Biol Psychiatry. 2017 Jan 1;81(1):31-42. doi: 10.1016/j.biopsych.2016.03.2104. Epub 2016 Mar 31. Review.

PMID:
27206569
12.

Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex.

Li YC, Yang SS, Gao WJ.

Neuropharmacology. 2016 Sep;108:403-14. doi: 10.1016/j.neuropharm.2016.05.002. Epub 2016 May 6.

13.

Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.

Papaleo F, Yang F, Paterson C, Palumbo S, Carr GV, Wang Y, Floyd K, Huang W, Thomas CJ, Chen J, Weinberger DR, Law AJ.

J Neurosci. 2016 Apr 27;36(17):4859-75. doi: 10.1523/JNEUROSCI.4632-15.2016.

14.

Optogenetic approaches to evaluate striatal function in animal models of Parkinson disease.

Parker KL, Kim Y, Alberico SL, Emmons EB, Narayanan NS.

Dialogues Clin Neurosci. 2016 Mar;18(1):99-107. Review.

15.

Mechanisms of Working Memory Impairment in Schizophrenia.

Van Snellenberg JX, Girgis RR, Horga G, van de Giessen E, Slifstein M, Ojeil N, Weinstein JJ, Moore H, Lieberman JA, Shohamy D, Smith EE, Abi-Dargham A.

Biol Psychiatry. 2016 Oct 15;80(8):617-26. doi: 10.1016/j.biopsych.2016.02.017. Epub 2016 Feb 23.

PMID:
27056754
16.

Effects of Sulpiride on True and False Memories of Thematically Related Pictures and Associated Words in Healthy Volunteers.

Guarnieri RV, Ribeiro RL, de Souza AA, Galduróz JC, Covolan L, Bueno OF.

Front Psychiatry. 2016 Mar 18;7:28. doi: 10.3389/fpsyt.2016.00028. eCollection 2016.

17.

Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.

Arnsten AF, Girgis RR, Gray DL, Mailman RB.

Biol Psychiatry. 2017 Jan 1;81(1):67-77. doi: 10.1016/j.biopsych.2015.12.028. Epub 2016 Jan 18. Review.

PMID:
26946382
18.

On the Complexity of Brain Disorders: A Symptom-Based Approach.

Moustafa AA, Phillips J, Kéri S, Misiak B, Frydecka D.

Front Comput Neurosci. 2016 Feb 23;10:16. doi: 10.3389/fncom.2016.00016. eCollection 2016.

19.
20.

Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.

Nørbak-Emig H, Ebdrup BH, Fagerlund B, Svarer C, Rasmussen H, Friberg L, Allerup PN, Rostrup E, Pinborg LH, Glenthøj BY.

Int J Neuropsychopharmacol. 2016 Apr 29;19(5). pii: pyw006. doi: 10.1093/ijnp/pyw006. Print 2016 May.

Supplemental Content

Support Center